FORMĂ CRISTALINĂ B A 4-(5-METIL-3-FENILIZOXAZOL-4-IL) BENZENSULFONAMIDEI

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO120771

Date: 28.07.2006

Inventor(s):

TALLEY JOHN J [US]

MEDICH JOHN R [US]

MCLAUGHLIN KATHLEEN T [US]

GAUD HENRY T [US]

YONAN EDWARD E [US]

Applicant(s):
SEARLE & CO [US]
Classification:
International patent classification (IPC):
A61K31/42; A61P19/02; A61P25/02; A61P29/00; A61P43/00; C07D261/08; H01L23/40; H01L23/427; C07D

Cooperative patent classification (CPC):
A61K31/42 (KR); A61P19/02 (EP); A61P25/02 (EP); A61P29/00 (EP); A61P43/00 (EP); C07D261/08 (EP, KR, US); H01L23/4006 (EP, US); H01L23/427 (EP, US); H01L2924/0002 (EP, US); H01L2924/0002; H01L2924/00
Application info:
No.: RO19990000176
Date: 12.08.1997
Priority number(s):
US19960024378P 14.08.1996 ; WO1997US15126 12.08.1997
Related patents:
AP1055; AR009244; ATE228117; AU4093697; AU722072; BG103155; BG64259; BR9711151; CA2264104; CN1205193; CN1233243; CZ297679; CZ33499; DE69717281; DK0920422; EA001472; EA003754; EA199900200; EA200000891; EE04237; EE9900053; EP0920422; EP1283203; ES2188971; GEP20022636; HK1023125; HU0400923; IL128255; IS1989; IS4961; JP2000506542; JP2005015497; JP3631763; KR100383148; KR20000029994; LT4551; LT99024; LV12274; NO312461; NO990541; NZ334132; OA11298; PL191313; PL331607; PT920422; RS49671; SI9720059; SK13699; SK283558; TR199900298; TW527350; UA52684; US2001003752; US2003004200; US6441014; US7135489; WO9806708; YU7499; ZA977314
Description:

Prezenta invenţie se referă la forma cristalină Ba 4-[5-metil-3-fenilizoxazol-4-il]benzensulfonamidei, la procedeul pentru prepararea acesteia, precum şi la utilizarea acestei forme cristaline pentru tratamentul sau prevenirea unei afecţiuni asociată cu ciclooxigenaza-2 (COX-2), inclusiv pentru tratamentul inflamaţiei, a artritei, a durerii şi a febrei.